Concepedia

Kevin N. Heller

KN

Statistics

Publications

13

Citations

1.6K

H-Index

12

Active since

2006

Affiliations

Bristol-Myers Squibb (United States)(Current)

Memorial Sloan Kettering Cancer Center

Rockefeller University

Angeles Clinic and Research Institute

Columbia University Irving Medical Center

Kevin N. Heller is an author at Bristol-Myers Squibb (United States) specializing in immunology, immunotherapy, and oncology.

Publications per year

2006–2021

13

Publications

13

Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial

Kim Margolin, Marc S. Ernstoff, Omid Hamid et al. · The Lancet Oncology · 2012 · 1.1K citations

, , +12

Ipilimumab efficacy and safety in patients with advanced melanoma: a retrospective analysis of HLA subtype from four trials.

Jedd D. Wolchok, Jeffrey S. Weber, Omid Hamid et al. · PubMed · 2010 · 125 citations · Full text

, , +17

Children with endemic Burkitt lymphoma are deficient in EBNA1‐specific IFN‐γ T cell responses

Ann M. Moormann, Kevin N. Heller, Kiprotich Chelimo et al. · International Journal of Cancer · 2008 · 67 citations · Full text

, , +9

Distinct memory CD4+ T-cell subsets mediate immune recognition of Epstein Barr virus nuclear antigen 1 in healthy virus carriers

Kevin N. Heller, Jenica Upshaw, Beza Seyoum et al. · Blood · 2006 · 57 citations · Full text

, , +16

Case Report: Response to Ipilimumab in a Patient With HIV With Metastatic Melanoma

Matthew M. Burke, Harriet M. Kluger, Marjorie Golden et al. · Journal of Clinical Oncology · 2011 · 38 citations

, , +11

1–5 of 13